Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia
2024 · EBioMedicine · 4 citations
https://doi.org/10.1016/j.ebiom.2024.105316
S
S Federico Pedicona
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
4
Citations
1
h-index
0
i10-index
S Federico Pedicona is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Cancer Genomics and Diagnostics & Retinoids in leukemia and cellular processes. The author has an h-index of 1, co-authored 1 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat